MAYVILLE, NY (May 4, 2026) – In addition to May being Mental Health Awareness Month, the week of May 3-9, 2026, is Tardive Dyskinesia Awareness Week. To raise awareness about tardive dyskinesia, the nonprofit Rural Minds has launched an educational webpage, “Tardive Dyskinesia: What You Need to Know,” with generous support from Neurocrine Biosciences and Teva Pharmaceutical Industries.
Tardive dyskinesia (TD) is a movement disorder that causes uncontrolled, repetitive movements of the face, body, or both that can impact a person’s professional, educational, social, and emotional life. These movements can include blinking, grimacing, lip-smacking, or jerking motions of the arms, legs, or torso, and they are not within a person’s control. The condition is associated with the use of antipsychotic medications that may be necessary to treat people living with mental illness.
In line with its mission to provide educational content to promote mental wellness and confront the stigma that can surround mental illness in rural communities, Rural Minds has designed the new online information hub to provide factual information and support around an often-misunderstood condition.
Content on the TD webpage provides an overview of tardive dyskinesia and includes a new, brief video with a healthcare professional who is an expert in screening for TD. The video covers what causes TD, signs and symptoms, and the importance of early diagnosis and screening for the condition. While the option of virtual screening for TD has some limitations compared with in-person screening, it may be preferred by people living in a rural area who travel greater distances to meet with a healthcare provider.
“We are pleased to feature this educational content on the Rural Minds website. It will help people living with TD in rural America and those who care for them to better understand the diagnosis and treatment of tardive dyskinesia,” says Rural Minds Founder and Chairman Jeff Winton. “The webpage also provides access to a TD fact sheet, blog post, recorded webinar on managing tardive dyskinesia in rural America, and access to TD online information and resources.”
Visit the new webpage, “Tardive Dyskinesia: What You Need to Know,” at www.ruralminds.org/tdawareness
About Rural Minds
Rural Minds™ is a 501(c)(3) nonprofit organization with the mission to serve as the informed voice for mental health in rural America and to provide mental health information and resources. Rural Minds is the only national 501(c)(3) nonprofit focused on advocating for rural mental health equity, promoting mental wellness, and providing educational content to confront rural mental health challenges and the stigma that surrounds mental illness for the 46 million people living in farming, ranching, and agriculture communities, small towns, and isolated areas across rural America. To learn more visit www.ruralminds.org.
About Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.
About Neurocrine Biosciences
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, endocrine, psychiatric and immunological disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and Y
